NewcelX

NCELNasdaq Switzerland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$17.821 M

$3.31 -0.90%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$8.30M

Loss-making

Shares outstanding

4,797,505

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#404Marker TherapeuticsMRKR$18.7M
#405Skye BioscienceSKYE$18.3M
#406NewcelXNCEL$17.8M
#407LipocineLPCN$17.6M
#408Pasithea TherapeuticsKTTA$16.9M

Where these numbers come from

Share counts and financials for NewcelX are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.